|
|
||||||||
Clinical Chemistry, Vol 41, 367-374, Copyright © 1995 by American Association for Clinical Chemistry
CA Spencer, M Takeuchi, M Kazarosyan, F MacKenzie, GJ Beckett and E Wilkinson
University of Southern California, Department of Medicine, Los Angeles 90033.
Clinically relevant interassay precision profiles for thyrotropin (thyroid-stimulating hormone; TSH) were constructed with human serum pools measured over 4-8 weeks by six immunometric assays, in at least two different reagent lots. Functional sensitivities (the concentration at which the interassay CV is < or = 20%) were determined in four to eight clinical laboratories plus the respective manufacturer's laboratory. These studies revealed that the manufacturer's stated functional sensitivity limit is rarely duplicated in clinical practice. Loss of specificity (indicated by artifactually high values) was seen with some methods when used to measure certain unrefrigerated low-TSH sera. Measurement of TSH in four human serum pools (TSH < 0.05-0.25 mIU/L) by 16 different methods (each in at least eight UK or US laboratories) showed that some methods could not reliably distinguish subnormal from normal TSH values. Better pool rankings and fewer misclassifications of low-TSH sera as "normal" were seen with use of assays capable of "third-generation" functional sensitivity (0.01-0.02 mIU/L) than with assays with "second-generation" functional sensitivity (0.1-0.2 mIU/L). Because inter- and intramethod differences in functional sensitivity negatively impact the diagnostic accuracy and cost-effectiveness of a TSH-centered thyroid-testing strategy, laboratories should independently establish an assay's functional sensitivity by a clinically relevant protocol. Moreover, manufacturers should assess functional sensitivity more realistically and improve the robustness of assays to ensure that their performance potential is consistently met in clinical practice.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Boas, J. L. Forman, A. Juul, U. Feldt-Rasmussen, N. E. Skakkebaek, L. Hilsted, M. Chellakooty, T. Larsen, J. F. Larsen, J. H Petersen, et al. Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women Eur. J. Endocrinol., December 1, 2009; 161(6): 903 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zophel, G. Wunderlich, and J. Kotzerke Should We Really Determine a Reference Population for the Definition of Thyroid-Stimulating Hormone Reference Interval? Clin. Chem., February 1, 2006; 52(2): 329 - 330. [Full Text] [PDF] |
||||
![]() |
S. Donadio, A. Pascual, J. H.H. Thijssen, and C. Ronin Feasibility Study of New Calibrators for Thyroid-Stimulating Hormone (TSH) Immunoprocedures Based on Remodeling of Recombinant TSH to Mimic Glycoforms Circulating in Patients with Thyroid Disorders Clin. Chem., February 1, 2006; 52(2): 286 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Li, T. Chuang, S. Tse, D. Hovanec-Burns, and A. S. El Shami Development and Validation of a Third Generation Allergen-Specific IgE Assay on the Continuous Random Access IMMULITE(R) 2000 Analyzer Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Uettwiller-Geiger, A. H.B. Wu, F. S. Apple, A. W. Jevans, P. Venge, M. D. Olson, C. Darte, D. L. Woodrum, S. Roberts, and S. Chan Multicenter Evaluation of an Automated Assay for Troponin I Clin. Chem., June 1, 2002; 48(6): 869 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Becker, T. Piironen, J. Kiviniemi, H. Lilja, and K. Pettersson Sensitive and Specific Immunodetection of Human Glandular Kallikrein 2 in Serum Clin. Chem., February 1, 2000; 46(2): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Sadler, M. H. Smith, L. M. Murray, and J. G. Turner A pragmatic approach to estimating total analytical error of immunoassays Clin. Chem., April 1, 1997; 43(4): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. McIver, P. Rae, G. Beckett, E. Wilkinson, A. Gold, and A. Toft Lack of Effect of Thyroxine in Patients with Graves' Hyperthyroidism Who Are Treated with an Antithyroid Drug N. Engl. J. Med., January 25, 1996; 334(4): 220 - 224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |